124 related articles for article (PubMed ID: 36426415)
1. COVID associated pulmonary mucormycosis: Outcomes of surgical therapy.
Pulle MV; Bishnoi S; Asaf BB; Puri HV; Deshwal V; Kumar A
Asian Cardiovasc Thorac Ann; 2023 Feb; 31(2):133-141. PubMed ID: 36426415
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of early anti-fungal therapy with aggressive surgical resection in pulmonary mucormycosis.
Pulle MV; Puri HV; Asaf BB; Bishnoi S; Sharma S; Kumar A
Lung India; 2021; 38(4):314-320. PubMed ID: 34259168
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of co-existent COVID-19-associated pulmonary aspergillosis (CAPA) and its impact on early mortality in patients with COVID-19-associated pulmonary mucormycosis (CAPM).
Muthu V; Agarwal R; Rudramurthy SM; Thangaraju D; Shevkani MR; Patel AK; Shastri PS; Tayade A; Bhandari S; Gella V; Savio J; Madan S; Hallur V; Maturu VN; Srinivasan A; Sethuraman N; Sibia RPS; Pujari S; Mehta R; Singhal T; Saxena P; Gupta V; Nagvekar V; Prayag P; Patel D; Xess I; Savaj P; Sehgal IS; Panda N; Rajagopal GD; Parwani RS; Patel K; Deshmukh A; Vyas A; Gandra RR; Sistla SK; Padaki PA; Ramar D; Panigrahi MK; Sarkar S; Rachagulla B; Vallandaramam P; Premachandran KP; Pawar S; Gugale P; Hosamani P; Dutt SN; Nair S; Kalpakkam H; Badhwar S; Kompella KK; Singla N; Navlakhe M; Prayag A; Singh G; Dhakecha P; Chakrabarti A
Mycoses; 2024 May; 67(5):e13745. PubMed ID: 38767273
[TBL] [Abstract][Full Text] [Related]
4. Risk factors, mortality, and predictors of survival in COVID-19-associated pulmonary mucormycosis: a multicentre retrospective study from India.
Muthu V; Agarwal R; Rudramurthy SM; Thangaraju D; Shevkani MR; Patel AK; Shastri PS; Tayade A; Bhandari S; Gella V; Savio J; Madan S; Hallur V; Maturu VN; Srinivasan A; Sethuraman N; Singh Sibia RP; Pujari S; Mehta R; Singhal T; Saxena P; Gupta V; Nagvekar V; Prayag P; Patel D; Xess I; Savaj P; Sehgal IS; Panda N; Rajagopal GD; Parwani RS; Patel K; Deshmukh A; Vyas A; Gandra RR; Sistla SK; Padaki PA; Ramar D; Sarkar S; Rachagulla B; Vallandaramam P; Premachandran KP; Pawar S; Gugale P; Hosamani P; Dutt SN; Nair S; Kalpakkam H; Badhwar S; Kompella KK; Singla N; Navlakhe M; Prayag A; Singh G; Dhakecha P; Chakrabarti A
Clin Microbiol Infect; 2024 Mar; 30(3):368-374. PubMed ID: 38081413
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary Artery Pseudoaneurysm in COVID-19-Associated Pulmonary Mucormycosis: Case Series and Systematic Review of the Literature.
Pruthi H; Muthu V; Bhujade H; Sharma A; Baloji A; Ratnakara RG; Bal A; Singh H; Sandhu MS; Negi S; Chakrabarti A; Singhal M
Mycopathologia; 2022 Feb; 187(1):31-37. PubMed ID: 34936060
[TBL] [Abstract][Full Text] [Related]
6. Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India.
Muthu V; Agarwal R; Patel A; Kathirvel S; Abraham OC; Aggarwal AN; Bal A; Bhalla AS; Chhajed PN; Chaudhry D; Garg M; Guleria R; Krishnan RG; Kumar A; Maheshwari U; Mehta R; Mohan A; Nath A; Patel D; Rudramurthy SM; Saxena P; Sethuraman N; Singhal T; Soman R; Thangakunam B; Varghese GM; Chakrabarti A
Lancet Infect Dis; 2022 Sep; 22(9):e240-e253. PubMed ID: 35390293
[TBL] [Abstract][Full Text] [Related]
7. Cut it out! Thoracic surgeon's approach to pulmonary mucormycosis and the role of surgical resection in survival.
Multani A; Reveron-Thornton R; Garvert DW; Gomez CA; Montoya JG; Lui NS
Mycoses; 2019 Oct; 62(10):893-907. PubMed ID: 31173415
[TBL] [Abstract][Full Text] [Related]
8. Video-assisted thoracoscopic lobectomy in non-small-cell lung cancer patients with chronic obstructive pulmonary disease is associated with lower pulmonary complications than open lobectomy: a propensity score-matched analysis.
Jeon JH; Kang CH; Kim HS; Seong YW; Park IK; Kim YT; Kim JH
Eur J Cardiothorac Surg; 2014 Apr; 45(4):640-5. PubMed ID: 24052605
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary Mucormycosis Treated With Lobectomy.
Afolayan O; Copeland H; Zaheer S; Wallen JM
Ann Thorac Surg; 2017 Jun; 103(6):e531-e533. PubMed ID: 28528060
[TBL] [Abstract][Full Text] [Related]
10. Histopathological Study of Mucormycosis in Post COVID-19 Patients and Factors Affecting it in a Tertiary Care Hospital.
Sree Lakshmi I; Kumari BS; Jyothi C; Devojee M; Padma Malini K; Sunethri P; Bheemrao Somalwar S; Kavitha T
Int J Surg Pathol; 2023 Feb; 31(1):56-63. PubMed ID: 35668640
[No Abstract] [Full Text] [Related]
11. A study of rhino-orbito-cerebral mucormycosis with COVID-19: A new challenge in North West of Rajasthan.
Kumar S; Kumar H; Mali M; Meena BL
Ann Afr Med; 2022; 21(4):383-389. PubMed ID: 36412339
[TBL] [Abstract][Full Text] [Related]
12. National perioperative outcomes of pulmonary lobectomy for cancer: the influence of nutritional status.
Thomas PA; Berbis J; Falcoz PE; Le Pimpec-Barthes F; Bernard A; Jougon J; Porte H; Alifano M; Dahan M;
Eur J Cardiothorac Surg; 2014 Apr; 45(4):652-9; discussion 659. PubMed ID: 24062351
[TBL] [Abstract][Full Text] [Related]
13. Predictors of Outcome in Modern Surgery for Lung Abscess.
Schweigert M; Solymosi N; Dubecz A; John J; West D; Boenisch PL; Karmy-Jones R; Ospina CFG; Almeida AB; Witzigmann H; Stein HJ
Thorac Cardiovasc Surg; 2017 Oct; 65(7):535-541. PubMed ID: 28249343
[No Abstract] [Full Text] [Related]
14. Sublobar resection versus lobectomy in Surgical Treatment of Elderly Patients with early-stage non-small cell lung cancer (STEPS): study protocol for a randomized controlled trial.
Yang F; Sui X; Chen X; Zhang L; Wang X; Wang S; Wang J
Trials; 2016 Apr; 17():191. PubMed ID: 27053091
[TBL] [Abstract][Full Text] [Related]
15. Surgical Treatment of Multifocal Pulmonary Mucormycosis.
Mills SEA; Yeldandi AV; Odell DD
Ann Thorac Surg; 2018 Aug; 106(2):e93-e95. PubMed ID: 29391149
[TBL] [Abstract][Full Text] [Related]
16. Oral manifestations, risk factors and management strategies of COVID-19 associated mucormycosis in tertiary care hospital.
Goel P; Kumar J; Rai A; Shakti P; Chouksey G
Indian J Dent Res; 2023; 34(2):155-158. PubMed ID: 37787203
[TBL] [Abstract][Full Text] [Related]
17. Early pneumonectomy for pulmonary mucormycosis.
Vercillo MS; Liptay MJ; Seder CW
Ann Thorac Surg; 2015 Mar; 99(3):e67-8. PubMed ID: 25742861
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary resection with chest wall removal and reconstruction for invasive pulmonary mucormycosis during antileukemia chemotherapy.
Asai K; Suzuki K; Takahashi T; Ito Y; Kazui T; Kita Y
Jpn J Thorac Cardiovasc Surg; 2003 Apr; 51(4):163-6. PubMed ID: 12723589
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and short-term outcomes of postoperative pulmonary complications after VATS lobectomy.
Agostini PJ; Lugg ST; Adams K; Smith T; Kalkat MS; Rajesh PB; Steyn RS; Naidu B; Rushton A; Bishay E
J Cardiothorac Surg; 2018 Apr; 13(1):28. PubMed ID: 29673386
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary mucormycosis: results of medical and surgical therapy.
Tedder M; Spratt JA; Anstadt MP; Hegde SS; Tedder SD; Lowe JE
Ann Thorac Surg; 1994 Apr; 57(4):1044-50. PubMed ID: 8166512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
